Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
957 hedge funds and large institutions have $55.5B invested in Allergan plc in 2019 Q4 according to their latest regulatory filings, with 134 funds opening new positions, 276 increasing their positions, 399 reducing their positions, and 85 closing their positions.
58% more first-time investments, than exits
New positions opened: 134 | Existing positions closed: 85
15% more capital invested
Capital invested by funds: $48.3B → $55.5B (+$7.24B)
13% more funds holding in top 10
Funds holding in top 10: 99 → 112 (+13)
4% more funds holding
Funds holding: 921 → 957 (+36)
31% less repeat investments, than reductions
Existing positions increased: 276 | Existing positions reduced: 399
64% less call options, than puts
Call options by funds: $730M | Put options by funds: $2.04B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$386M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$374M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$317M |
| 4 |
Renaissance Technologies
New York
|
+$243M |
| 5 |
ACM
Abrams Capital Management
Boston,
Massachusetts
|
+$223M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$514M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$410M |
| 3 |
ClearBridge Investments
New York
|
-$337M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$320M |
| 5 |
MP
MFN Partners
Boston,
Massachusetts
|
-$236M |
AGN Hedge Fund Activity: Q4 2019 in Review
957 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q4 2019, worth a combined $55.5B — up 15% from $48.3B a quarter earlier.
Buyers outnumbered sellers: 134 funds opened new AGN positions and 85 closed out — a net gain of 49 holders — while 276 added to existing stakes and 399 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $386M. The largest seller was JP Morgan Chase, cutting an estimated $514M.
- 957 institutional investors held Allergan plc (AGN) as of Q4 2019, up from 921 in Q3 2019.
- Funds reported $55.5B of Allergan plc stock for Q4 2019, up 15% quarter-over-quarter.
- 134 funds opened new Allergan plc positions in Q4 2019 and 85 closed out, a net change of +49 holders.
- The largest Allergan plc buyer in Q4 2019 was Goldman Sachs, an estimated $386M added.
- The largest Allergan plc seller in Q4 2019 was JP Morgan Chase, an estimated $514M sold.
Based on aggregated 13F filings for Q4 2019.